Sinergium Biotech is an Argentine biopharmaceutical company specialized in the research, development, production and marketing of highly complex vaccines and biopharmaceutical products.
With unique characteristics worldwide, it carries out an innovative production model of strategic alliances with national and international laboratories that allows: the transfer and availability of cutting-edge technologies, autonomy in the production and supply of strategic products that previously had to be imported, the generation of new job sources with highly qualified professionals, the substitution of imports and the generation of an important export potential.
During the influenza A (H1N1) pandemic, the need for a local vaccine production plant in Argentina became evident. In 2010 and in alliance with the Swiss company Novartis , the technology transfer process for the local production of influenza vaccines in the country began. In July 2015 bioCSL (a company of the Australian CSL group) and the Novartis influenza vaccine division joined forces to create Seqirus , the second largest company in the world for the production of this vaccine.
This agreement was followed by alliances with North American companies: Pfizer, for the production of the pneumococcal conjugate vaccine, and MSD (Merck, Sharp & Dohme, an Argentine subsidiary of Merck & Co) for the production of the quadrivalent vaccine against HPV. In turn, for the production of monoclonal antibodies, Sinergium Biotech joins the Elea Laboratory, Chemo (with its biotechnological company mAbxience ) and PharmADN who form a public-private consortium together with the Roffo Institute (UBA), the University of Quilmes and the MinCyT
Our values
Responsibility and commitmentAppropriate and promote the values, policies and procedures established by the organization and all current legal regulations. Inspire confidence developing with enthusiasm, dedication, initiative and perseverance.
NetworkingThe promotion of interpersonal relationships in good faith inside and outside the company based on respect and collaboration, encourages integration in a good work environment and the achievement of organizational objectives.
FlexibilityAdapting easily and responding effectively to changes in the context is a core competency for our company. Be open to listening, understanding and assimilating other points of view, adopting them as your own when circumstances require it.
Results-oriented always seek excellence in meeting the objectives of the company, the sector and/or position, contemplating the transversal impact of their actions, overcoming difficulties, accepting and/or suggesting opportunities for improvement.
InnovationImplement and develop new approaches and techniques to generate solutions that add value. We encourage teams and peers to develop new concepts, methods and approaches in pursuit of continuous improvement and professional ethics.
